Is that relevant to both conditions?

I think the progress in research particularly has been really transformative in IBD.

And the reason for that kind of goes back to Orla's point is that IBD is relatively easily diagnosed compared to IBS.

And this has been there for a very long period of time.

So you touched upon that point, is that there is a huge amount of data, not just from within Ireland, you know, that 40,000 patient cohort that I mentioned about before, but globally as well.

And as we are advancing in our technologies, you know, particularly with the eye, the idea is that how can we combine different data types that we've collected from patients.

So from a given patient, you're looking at, you know, their biochemical markers, so Orla talked about C-reactive protein.

Siddipto, if we can come to you in terms of treatment, research, what's exciting out there? What's really on fire now that's coming down the road for everybody?